Nucor Corporation
Nucor Corporation (0K9L.L) Financial Performance & Income Statement Overview
Explore the financials of Nucor Corporation (0K9L.L), including yearly and quarterly data on income, cash flow, and balance sheets.
Nucor Corporation (0K9L.L) Income Statement & Financial Overview
View the income breakdown for Nucor Corporation 0K9L.L across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $8.46B | $7.83B | $7.08B | $7.44B |
| Cost of Revenue | $7.23B | $7.22B | $6.45B | $6.69B |
| Gross Profit | $1.22B | $605.00M | $627.00M | $757.93M |
| Gross Profit Ratio | $0.14 | $0.08 | $0.09 | $0.10 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $281.00M | $240.00M | $244.66M |
| Operating Expenses | $0.00 | $281.00M | $240.00M | $244.66M |
| Total Costs & Expenses | $0.00 | $7.51B | $6.69B | $6.93B |
| Interest Income | $0.00 | $37.00M | $49.47M | $0.00 |
| Interest Expense | $19.00M | $51.00M | $52.28M | $7.28M |
| Depreciation & Amortization | $0.00 | $368.00M | $358.06M | $350.46M |
| EBITDA | $0.00 | $704.00M | $745.06M | $863.74M |
| EBITDA Ratio | $0.00 | $0.09 | $0.11 | $0.12 |
| Operating Income | $0.00 | $324.00M | $386.96M | $513.28M |
| Operating Income Ratio | $0.00 | $0.04 | $0.05 | $0.07 |
| Other Income/Expenses (Net) | $0.00 | -$39.00M | $3.00M | -$125.004M |
| Income Before Tax | $796.00M | $285.00M | $390.00M | $388.27M |
| Income Before Tax Ratio | $0.09 | $0.04 | $0.06 | $0.05 |
| Income Tax Expense | $193.00M | $59.00M | $45.00M | $85.45M |
| Net Income | $603.00M | $156.00M | $287.03M | $249.91M |
| Net Income Ratio | $0.07 | $0.02 | $0.04 | $0.03 |
| EPS | $2.60 | $0.67 | $1.22 | $1.05 |
| Diluted EPS | $2.60 | $0.67 | $1.22 | $1.05 |
| Weighted Avg Shares Outstanding | $230.60M | $232.70M | $234.00M | $236.46M |
| Weighted Avg Shares Outstanding (Diluted) | $230.80M | $232.90M | $234.30M | $236.77M |
Over the past four quarters, Nucor Corporation demonstrated steady revenue growth, increasing from $7.44B in Q3 2024 to $8.46B in Q2 2025. Operating income reached $0.00 in Q2 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to $603.00M, with EPS at $2.60. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan